Cargando…
Pan-Cancer Analysis and Drug Formulation for GPR139 and GPR142
GPR (G protein receptor) 139 and 142 are novel foundling GPCRs (G protein-coupled receptors) in the class “A” of the GPCRs family and are suitable targets for various biological conditions. To engage these targets, validated pharmacophores and 3D QSAR (Quantitative structure-activity relationship) m...
Autores principales: | Kaushik, Aman Chandra, Mehmood, Aamir, Dai, Xiaofeng, Wei, Dong-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933564/ https://www.ncbi.nlm.nih.gov/pubmed/33679382 http://dx.doi.org/10.3389/fphar.2020.521245 |
Ejemplares similares
-
An Integrated Pan-Cancer Analysis and Structure-Based Virtual Screening of GPR15
por: Wang, Yanjing, et al.
Publicado: (2019) -
Re-evaluation of Adrenocorticotropic Hormone and Melanocyte Stimulating Hormone Activation of GPR139 in Vitro
por: Nepomuceno, Diane, et al.
Publicado: (2018) -
The therapeutic potential of orphan GPCRs, GPR35 and GPR55
por: Shore, Derek M., et al.
Publicado: (2015) -
In vivo Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 Agonist
por: Shoblock, James R., et al.
Publicado: (2019) -
Structure Based Virtual Screening Studies to Identify Novel Potential Compounds for GPR142 and Their Relative Dynamic Analysis for Study of Type 2 Diabetes
por: Kaushik, Aman C., et al.
Publicado: (2018)